位置:首页 > 蛋白库 > USTA_ASPFN
USTA_ASPFN
ID   USTA_ASPFN              Reviewed;         237 AA.
AC   B8NM66;
DT   05-OCT-2016, integrated into UniProtKB/Swiss-Prot.
DT   03-MAR-2009, sequence version 1.
DT   03-AUG-2022, entry version 43.
DE   RecName: Full=Ribosomally synthesized cyclic peptide ustiloxin B precursosr {ECO:0000303|PubMed:24841822};
DE   AltName: Full=Ustiloxin B biosynthesis protein A {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-I {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-II {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-III {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-IV {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-V {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-VI {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-VII {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-VIII {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-IX {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-X {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-XI {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-XII {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-XIII {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-XIV {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-XV {ECO:0000303|PubMed:24841822};
DE   Contains:
DE     RecName: Full=YAIG-XVI {ECO:0000303|PubMed:24841822};
DE   Flags: Precursor;
GN   Name=ustA {ECO:0000303|PubMed:24841822}; ORFNames=AFLA_094980;
OS   Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357
OS   / JCM 12722 / SRRC 167).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC   Aspergillus subgen. Circumdati.
OX   NCBI_TaxID=332952;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC
RC   167;
RX   PubMed=25883274; DOI=10.1128/genomea.00168-15;
RA   Nierman W.C., Yu J., Fedorova-Abrams N.D., Losada L., Cleveland T.E.,
RA   Bhatnagar D., Bennett J.W., Dean R., Payne G.A.;
RT   "Genome sequence of Aspergillus flavus NRRL 3357, a strain that causes
RT   aflatoxin contamination of food and feed.";
RL   Genome Announc. 3:E0016815-E0016815(2015).
RN   [2]
RP   FUNCTION, DISRUPTION PHENOTYPE, CLEAVAGE BY KEX2, AND POST-TRANSLATIONAL
RP   MODIFICATIONS TO YIELD USTILOXIN B.
RX   PubMed=24841822; DOI=10.1016/j.fgb.2014.04.011;
RA   Umemura M., Nagano N., Koike H., Kawano J., Ishii T., Miyamura Y.,
RA   Kikuchi M., Tamano K., Yu J., Shin-ya K., Machida M.;
RT   "Characterization of the biosynthetic gene cluster for the ribosomally
RT   synthesized cyclic peptide ustiloxin B in Aspergillus flavus.";
RL   Fungal Genet. Biol. 68:23-30(2014).
RN   [3]
RP   FUNCTION, AND POST-TRANSLATIONAL MODIFICATIONS TO YIELD USTILOXIN B.
RX   PubMed=27166860; DOI=10.1002/anie.201602611;
RA   Ye Y., Minami A., Igarashi Y., Izumikawa M., Umemura M., Nagano N.,
RA   Machida M., Kawahara T., Shin-Ya K., Gomi K., Oikawa H.;
RT   "Unveiling the biosynthetic pathway of the ribosomally synthesized and
RT   post-translationally modified peptide ustiloxin B in filamentous fungi.";
RL   Angew. Chem. Int. Ed. 55:8072-8075(2016).
RN   [4]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND POST-TRANSLATIONAL MODIFICATIONS TO
RP   YIELD USTILOXIN B.
RX   PubMed=26703898; DOI=10.1016/j.fgb.2015.12.010;
RA   Nagano N., Umemura M., Izumikawa M., Kawano J., Ishii T., Kikuchi M.,
RA   Tomii K., Kumagai T., Yoshimi A., Machida M., Abe K., Shin-ya K., Asai K.;
RT   "Class of cyclic ribosomal peptide synthetic genes in filamentous fungi.";
RL   Fungal Genet. Biol. 86:58-70(2016).
CC   -!- FUNCTION: Ribosomally synthesized cyclic peptide ustiloxin B precursor:
CC       Part of the gene cluster that mediates the biosynthesis of the
CC       secondary metabolite ustiloxin B, an antimitotic tetrapeptide
CC       (PubMed:24841822). The ustA translated product contains a 16-fold
CC       repeated peptide embedding the tetrapeptide Tyr-Ala-Ile-Gly, that is
CC       converted into the cyclic moiety of ustiloxin B (PubMed:24841822).
CC       {ECO:0000269|PubMed:24841822}.
CC   -!- PATHWAY: Mycotoxin biosynthesis. {ECO:0000269|PubMed:24841822}.
CC   -!- PTM: UstA is processed by the subtilisin-like endoprotease kex2 that is
CC       outside the ustiloxin B gene cluster, at the C-terminal side of Arg-
CC       Lys, after transfer to Golgi apparatus through the endoplasmic
CC       reticulum (ER) (PubMed:24841822). Cleavage by kex2 generates 16
CC       peptides YAIG-I to YAIG-XVI (PubMed:24841822). To process the precursor
CC       peptide further, at least two peptidases are necessary to cleave the N-
CC       terminal and C-terminal sides of the Tyr-Ala-Ile-Gly core peptide which
CC       serves as backbone for the synthesis of ustiloxin B, through
CC       cyclization and modification of the tyrosine (PubMed:24841822). One of
CC       the two peptidases must be the serine peptidase ustP; and the other
CC       pepdidase is probably ustH (PubMed:24841822). Macrocyclization of the
CC       core peptide derived from ustA requires the tyrosinase ustQ, as well as
CC       the homologous oxidases ustYa and ustYb, and leads to the production of
CC       the first cyclization product N-desmethylustiloxin F (PubMed:27166860,
CC       PubMed:26703898). For the formation of N-desmethylustiloxin F, three
CC       oxidation steps are required, hydroxylation at the benzylic position,
CC       hydroxylation at either the aromatic ring of Tyr or beta-position of
CC       Ile, and oxidative cyclization (PubMed:27166860). UstQ may catalyze the
CC       oxidation of a phenol moiety, whereas the ustYa and ustYb are most
CC       likely responsible for the remaining two-step oxidations
CC       (PubMed:27166860). N-desmethylustiloxin F is then methylated by ustM to
CC       yield ustiloxin F which in turn substrate of the cytochrome P450
CC       monooxygenase ustC which catalyzes the formation of S-deoxyustiloxin H
CC       (PubMed:27166860). The flavoprotein monooxygenases ustF1 and ustF2 then
CC       participate in the modification of the side chain of S-deoxyustiloxin
CC       H, leading to the synthesis of an oxime intermediate, via ustiloxin H
CC       (PubMed:27166860). Finally, carboxylative dehydration performed by the
CC       cysteine desulfurase-like protein ustD yields ustiloxin B
CC       (PubMed:27166860). {ECO:0000269|PubMed:24841822,
CC       ECO:0000269|PubMed:26703898, ECO:0000269|PubMed:27166860}.
CC   -!- DISRUPTION PHENOTYPE: Impairs the production of ustiloxin B and its
CC       intermediate ustiloxin F (PubMed:24841822, PubMed:26703898).
CC       {ECO:0000269|PubMed:24841822, ECO:0000269|PubMed:26703898}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EQ963480; EED49417.1; -; Genomic_DNA.
DR   RefSeq; XP_002381318.1; XM_002381277.1.
DR   AlphaFoldDB; B8NM66; -.
DR   STRING; 332952.B8NM66; -.
DR   EnsemblFungi; EED49417; EED49417; AFLA_094980.
DR   VEuPathDB; FungiDB:AFLA_094980; -.
DR   eggNOG; ENOG502SJ4U; Eukaryota.
DR   HOGENOM; CLU_1384495_0_0_1; -.
DR   OMA; VEDYAIG; -.
DR   Proteomes; UP000001875; Unassembled WGS sequence.
PE   1: Evidence at protein level;
KW   Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   PROPEP          20..22
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437276"
FT   CHAIN           23..35
FT                   /note="YAIG-I"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_5002878297"
FT   CHAIN           36..48
FT                   /note="YAIG-II"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437277"
FT   CHAIN           49..61
FT                   /note="YAIG-III"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437278"
FT   CHAIN           62..74
FT                   /note="YAIG-IV"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437279"
FT   CHAIN           75..87
FT                   /note="YAIG-V"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437280"
FT   CHAIN           88..100
FT                   /note="YAIG-VI"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437281"
FT   CHAIN           101..113
FT                   /note="YAIG-VII"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437282"
FT   CHAIN           114..126
FT                   /note="YAIG-VIII"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437283"
FT   CHAIN           127..139
FT                   /note="YAIG-IX"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437284"
FT   CHAIN           140..152
FT                   /note="YAIG-X"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437285"
FT   CHAIN           153..166
FT                   /note="YAIG-XI"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437286"
FT   CHAIN           167..179
FT                   /note="YAIG-XII"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437287"
FT   CHAIN           180..192
FT                   /note="YAIG-XIII"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437288"
FT   CHAIN           193..206
FT                   /note="YAIG-XIV"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437289"
FT   CHAIN           207..219
FT                   /note="YAIG-XV"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437290"
FT   CHAIN           220..233
FT                   /note="YAIG-XVI"
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437291"
FT   PROPEP          234..237
FT                   /evidence="ECO:0000305|PubMed:24841822"
FT                   /id="PRO_0000437292"
SQ   SEQUENCE   237 AA;  26055 MW;  0B73041EFE0EF39D CRC64;
     MKLILTLLVS GLCALAAPAA KRDGVEDYAI GIDKRNSVED YAIGIDKRNS VEDYAIGIDK
     RNSVEDYAIG IDKRNSVEDY AIGIDKRNTV EDYAIGIDKR NSVEDYAIGI DKRNTVEDYA
     IGIDKRNSVE DYAIGIDKRN SVEDYAIGID KRGGSVEDYA IGIDKRNSVE DYAIGIDKRN
     SVEDYAIGID KRGSVEDYAI GIDKKRGTVE DYAIGIDKRG GSVEDYAIGI DKRHGGH
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024